Category
Boris-Enock Zinsou
Boris-Enock
Zinsou
Research Theme
WWARN

Boris-Enock Zinsou is a PhD candidate in Public Health at Université Paris Cité (IRD - MERIT) under the joint supervision of Dr. Jérôme Clain (IRD – MERIT), Professor Philippe Guérin, and Dr. Lucinda Harrison. Within the IDDO, his research focuses on the spatial, genetic, and epidemiological dynamics of Plasmodium falciparum resistance to antimalarial drugs in West Africa and the Sahel, particularly in the context of chemoprevention strategies.

He holds a Master’s degree in Public Health from the École Pasteur-Cnam de Santé Publique (France), a Master’s degree in Microbiology from Cheikh Anta Diop University (Senegal), and a Bachelor’s degree in Biomedical Analysis from the University of Abomey-Calavi (Benin).

Before starting his PhD, Boris-Enock Zinsou began his career as a research engineer in virology at the Virology Department of the Institut Pasteur in Dakar (Senegal), where he contributed to the WHO Global Polio Eradication Program, ensuring virological surveillance for six West African countries.

During the COVID-19 pandemic, he joined the Reference Laboratory for Viral Hemorrhagic Fevers in Cotonou (Benin), where he participated in diagnostic activities.

He then served as a biological engineer and laboratory manager at the Clinical Research Institute of Benin (IRCB). He played a key role in a multicenter clinical trial evaluating the efficacy of a triple therapy against uncomplicated malaria in African children.

Finally, he worked as a consultant biologist for the Ministry of Health of Benin, the U.S. Centers for Disease Control and Prevention (CDC), and SIGHTSAVERS, where he contributed to the evaluation of new diagnostic tools for onchocerciasis.

His research interests include epidemiology, disease modeling, and infectious disease control, with a particular focus on challenges related to climate change and fragile health systems, especially in resource-limited settings.

Category
Dr Thel Hla
Dr
Thel
Hla
Visiting Researcher
Research Theme
Antimicrobial resistance

Dr Thel Hla is a visiting researcher with the IDDO antimicrobial resistance research team. She is an infectious diseases physician by training (MBBS, DTM&H, FRACP) and holds a senior research officer position with The Kids Research Institute (Australia). She has previously worked as a researcher with Myanmar Oxford Clinical Research Unit (MOCRU) in 2019 -2020. 

She is currently completing a doctoral thesis focussing on re-purposing penicillins to improve secondary prophylaxis against Strep A, centred around a randomised, controlled Strep A human challenge study. Her other research involvements include demonstration of safety and feasibility of subcutaneous infusion of high dose long-acting penicillin in healthy human volunteers, paving the way for improving treatment of syphilis infection and secondary prophylaxis of rheumatic heart disease. 

Category
Dr Mary Scott
Dr
Mary
Scott
Data Scientist
Research Theme
WWARN

Mary joined IDDO in January 2025 as a Data Scientist to perform large-scale individual patient data meta-analyses, methods development, and statistical modelling to optimise the treatment of infectious disease. Her research will focus on improving the diagnosis and triage of patients with suspected severe malaria.

In February 2024, Mary defended her PhD thesis, titled 'Differentially Private Methods for Releasing Aggregated Multi-Dimensional Messages'. She holds a Bachelor of Science in Mathematics from the University of Warwick. 

Google Scholar profile

ORCiD profile

 

Category
Dr Dhruv Darji
Dr
Dhruv
Darji
DPhil student

Dhruv is a medical doctor from Zambia with a keen interest in the epidemiology of infectious diseases. At IDDO, Dhruv’s DPhil research focuses on Seasonal Malaria Chemoprevention, supervised by Prof. Philippe Guérin, Dr. James Watson and Dr. Prabin Dahal. 

Previously, Dhruv completed the MSc in Global Health Science and Epidemiology in Oxford. He is supported by the Rhodes Scholarship. He aims to pursue specialty clinical training after completing his doctoral research in Oxford. 

Category
Lucinda Harrison
Lucinda
Harrison
Researcher
Research Theme
WWARN

Lucy joined IDDO in November 2024 to work on geospatial models of anti-malarial drug resistance. Lucy has recently submitted her PhD thesis, titled “Informing public health decisions with geospatial models of vector-borne disease”. During her PhD, she developed geospatial models of Plasmodium knowlesi malaria in Southeast Asia and Japanese encephalitis virus in Australia. She also worked on frameworks for model-informed decision-making for disease surveillance site selection. 

Before commencing her PhD, she obtained a Bachelor of Science, majoring in Computational Biology, in 2018 and a Master of Computational Biology in 2020 from the University of Melbourne.

Category
Riley
Quah
Data Manager
Research Theme
WWARN
Visceral leishmaniasis
COVID19
Schistosomiasis & STHs
Chagas

Riley joined IDDO in September 2024. As a Data Manager, they work on the management and transformation of diverse data sets that are submitted to IDDO, as well as ensuring the completeness and accuracy of data in the IDDO data repository. 

Prior to joining IDDO, they worked as a Data Wrangler for the Oxford-Novartis collaboration where they handled big data from IL-17A inhibitor clinical trials.

Riley holds a MBiol Microbiology/Biotechnology from the University of York and a MSc Data Science from Loughborough University.

Category
Mr Thitthiphone Olinh
Thitthiphone
Olinh
Research Assistant
Medicine Quality Research Group, Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit
Research Theme
Medicine quality

Mr Thitthiphone Olinh is a graduate Bachelor's degree in Pharmaceutical Care from the University of Health Sciences in Laos. He co-founded Precious Plastic Vientiane, an initiative addressing plastic waste in Lao communities, promoting recycling and sustainable environmental practices. Additionally, Mr Thitthiphone conducted research on the knowledge and behavior of self-care among people who has Long COVID-19 in Vientiane Capital, further highlighting his commitment to advancing both health and environmental solutions in Laos. He joined the Medicine Quality Research group in April 2024 as a research assistant, based in Vientiane in the Lao-Oxford-Mahosot Hospital-Wellcome Trust-Research Unit (LOMWRU).

Category
Dr Forhad Chowdhury
Dr
Forhad
Chowdhury
DPhil student
Research Theme
Antimicrobial resistance
Visceral leishmaniasis

Forhad is a Bangladeshi consultant in medicine with a deep passion for sepsis, antimicrobial resistance (AMR), and conducting high-quality clinical trials in low-resource settings. He has been serving in the Bangladesh Civil Service since 2010, demonstrating a strong commitment to public health and clinical excellence. Forhad is a Commonwealth Scholar who was featured in the Yearbook 21 of the Commonwealth Scholarship Commission, UK. In recognition of his exceptional contributions during the COVID-19 pandemic, he received the prestigious Integrity Award 2021 from the Government of Bangladesh.

Forhad has co-authored the National Guidelines on Clinical Management of COVID-19 and the Standard Treatment Guidelines of Common Infections of Bangladesh, contributing significantly to national healthcare protocols. He also serves as a guest lecturer at the Liverpool School of Tropical Medicine, UK, where he shares his expertise with the next generation of healthcare professionals.

Currently, Forhad is conducting a systematic review to estimate the burden of AMR in Bangladesh in collaboration with Prof. Philippe Guerin at the Infectious Diseases Data Observatory (IDDO). He is also leading a randomized controlled trial to investigate the role of procalcitonin in reducing antibiotic therapy in adult sepsis patients under the supervision of Prof. Arjen Dondorp. Forhad’s work is driven by his dedication to improving healthcare standards and outcomes in resource-limited settings through rigorous research and clinical innovation.

Category
Aninda Nishat Moitry
Dr
Aninda
Moitry
DPhil student
Research Theme
WWARN

Dr Aninda Nishat Moitry is a DPhil in Clinical Medicine student based at the Infectious Diseases Data Observatory. She started her PhD in October 2023 under the supervision of Professor Philippe Guerin, and Drs. James Watson, Makoto Saito, and Stephanie Dellicour. Her doctoral research will investigate the safety of a range of antimalarial drugs used for treating acute malaria during pregnancy, with the goal to generate robust evidence to inform policy maker, regulators, clinicians, and pregnant women. 

Dr Moitry is a medical doctor by training and completed her MSc in Epidemiology from Imperial College London with Chevening Scholarship. She also gained an MPH from BRAC University, Bangladesh. She became a Fellow member of the Royal Society for Public Health (RSPH), United Kingdom in 2022. 

Prior to starting her PhD, Dr Moitry was working as an Assistant Professor at the University of Dhaka, Bangladesh. In addition to teaching Epidemiology and Public Health, she has worked on a number of research projects on maternal and child health, infectious diseases, and equity issues in health services utilisation in the last 7 years, and actively engaged in policy advocacy.

Category
Cindy Kesty
Cindy
Kesty
WHO/TDR Fellow
Research Theme
WWARN

Cindy is a WHO/TDR Clinical Research Leadership Fellow at Infectious Diseases Data Observatory, University of Oxford. Specifically, she will work on a malaria in pregnancy research project. She is interested in gaining more knowledge and skill about research and evidence-based medicine.

Before joining IDDO, Cindy worked as an Obstetrician and Gynecologist in Palembang, South Sumatra, Indonesia. She treated many healthy pregnant women and also those with diseases, such as hepatitis B, HIV, syphilis, tuberculosis, dengue hemorrhagic fever, etc. She graduated from Obstetrics and Gynecology Study Program at Faculty of Medicine Universitas Sriwijaya in 2022 and as a medical doctor at the same university in 2016. 

Cindy is a member of National Task Force of Reproductive Tract Infection Indonesian Society of Obstetrics and Gynecology. Their main concern is the antimicrobial resistance and triple elimination eradication program conducted by the Indonesian government for all pregnant women. It consists of Hepatitis B, HIV, and syphilis. Moreover, other endemic diseases in their country become their concern, such as malaria, tuberculosis, and DHF.